Inventor · disambiguated record
Catherine Leblanc
Also filed as: LEBLANC CATHERINE
35 granted patents·18 pending applications·124 citations·filing 2003–2022
96Inventor score
Top patents by PatentIndex Score
53 records- 0191US9533988B2Ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitorsBUSCHMANN NICOLE·Filed 2015·Granted Jan 3, 2017·13 cites·8 claims
- 0291US7666878B2Pyrrolopyridine derivatives and their use as Crth2 antagonistsNOVARTIS AG·Filed 2005·Granted Feb 23, 2010·16 cites·13 claims
- 0390US9266883B2Ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitorsBUSCHMANN NICOLE·Filed 2014·Granted Feb 23, 2016·16 cites·13 claims
- 0486US8314112B2Pyrrolopyrimidines and pyrrolopyridinesLEBLANC CATHERINE·Filed 2009·Granted Nov 20, 2012·12 cites·9 claims
- 0585US7989458B2Pyrimidine derivatives as alk-5 inhibitorsNOVARTIS AG·Filed 2007·Granted Aug 2, 2011·12 cites·18 claims
- 0682US8754085B2Pyrido[2,3-b]pyrazine compounds useful as IP receptor agonistCHARLTON STEVEN JOHN·Filed 2011·Granted Jun 17, 2014·8 cites·14 claims
- 0781US9132127B2Substituted pyrido[2,3-B]pyrazines as IP receptor agonistsCHARLTON STEVEN JOHN·Filed 2014·Granted Sep 15, 2015·6 cites·16 claims
- 0881US8367662B2Organic compoundsNOVARTIS AG·Filed 2008·Granted Feb 5, 2013·7 cites·8 claims
- 0980US8343966B2Organic compoundsNOVARTIS AG·Filed 2009·Granted Jan 1, 2013·6 cites·2 claims
- 1078US10130629B2Pharmaceutical combinationsNOVARTIS AG·Filed 2016·Granted Nov 20, 2018·3 cites·7 claims
- 1178US9896449B2Ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitorsBUSCHMANN NICOLE·Filed 2016·Granted Feb 20, 2018·2 cites·1 claims
- 1278US9802917B2Particles of N-(5-cyano-4-((2-methoxyethyl)amino)pyridin-2-yl)-7-formyl-6-((4-methyl-2-oxopiperazin-1-yl)methyl)-3,4-dihydro-1,8-naphthyridine-1(2H)-carboxamideBUSCHMANN NICOLE·Filed 2016·Granted Oct 31, 2017·2 cites·15 claims
- 1377US8455645B2Pyrrolopyridine derivatives and their use as CRTH2 antagonistsBALA KAMLESH JAGDIS·Filed 2010·Granted Jun 4, 2013·3 cites·10 claims
- 1474US8470848B2Organic compoundsBALA KAMLESH JAGDIS·Filed 2010·Granted Jun 25, 2013·2 cites·14 claims
- 1572US8791256B2Pyrrolopyridine derivatives and their use as CRTH2 antagonistsNOVARTIS AG·Filed 2013·Granted Jul 29, 2014·1 cites·1 claims
- 1672US7687637B25-phenylthiazole derivatives and use as Pi3 kinase inhibitorsNOVARTIS AG·Filed 2003·Granted Mar 30, 2010·7 cites·14 claims
- 1770US8129541B25-phenylthiazole derivatives and use as PI3 kinase inhibitorsBRUCE IAN·Filed 2009·Granted Mar 6, 2012·1 cites·15 claims
- 1869US9079897B2Imidazo-pyridine derivatives as activin-like receptor kinase (ALK4 or ALK5) inhibitorsLEBLANC CATHERINE·Filed 2009·Granted Jul 14, 2015·1 cites·7 claims
- 1968US8431578B2Organic compoundsHUNT PETER·Filed 2009·Granted Apr 30, 2013·2 cites·3 claims
- 2067US8937069B2Substituted pyrrolo[2,3-B]pyrazine compounds and their useNOVARTIS AG·Filed 2013·Granted Jan 20, 2015·1 cites·9 claims
- 2166US9174985B2Salts of 7-(2,3-di-p-tolyl-7,8-dihydropyrido[2,3-b]pyrazin-5(6H)-yl)heptanoic acid as IP receptor agonistsLEBLANC CATHERINE·Filed 2013·Granted Nov 3, 2015·1 cites·9 claims
- 2265US8431703B2Pyrrolopyridine compounds and their use in treating diseaseSANDHAM DAVID ANDREW·Filed 2006·Granted Apr 30, 2013·1 cites·5 claims
- 2364US7902375B25-phenyl-4-methyl-thiazol-2-yl-amine derivatives as inhibitors of phosphatidylin ositol 3 kinase enzymes (PI13) for treatment of inflammatory diseasesNOVARTIS AG·Filed 2004·Granted Mar 8, 2011·1 cites·2 claims
- 2463US9169251B2Pyrrolopyridine derivatives and their use as CRTH2 antagonistsNOVARTIS AG·Filed 2014·Granted Oct 27, 2015·0 cites·6 claims
- 2561US10786492B2Formylated N-heterocyclic derivatives as FGFR4 inhibitorsNOVARTIS AG·Filed 2018·Granted Sep 29, 2020·0 cites·1 claims
- 2659US2024317721A1Pyrazolyl derivatives as inhibitors of the kras mutant proteinNOVARTIS AG·Filed 2022·Application pending·0 cites
- 2756US10507201B2Use of ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitorsNOVARTIS AG·Filed 2019·Granted Dec 17, 2019·0 cites·17 claims
- 2856US2024366567A1Pharmaceutical combinations comprising a kras g12c inhibitor and uses thereof for the treatment of cancersNOVARTIS AG·Filed 2022·Application pending·0 cites
- 2954US10189813B2Formylated N-heterocyclic derivatives as FGFR4 inhibitorsBUSCHMANN NICOLE·Filed 2016·Granted Jan 29, 2019·0 cites·6 claims
- 3053US9073932B2Substituted pyrrolo[2,3-B]pyrazines for the treatment of disorders and diseasesNOVARTIS AG·Filed 2014·Granted Jul 7, 2015·0 cites·15 claims
- 3153US2024082218A1Pharmaceutical combinations comprising a kras g12c inhibitor and uses of a kras g12c inhibitor for the treatment of cancersNOVARTIS AG·Filed 2021·Application pending·0 cites
- 3252US12226405B2Compounds and compositions for inhibiting the activity of HIF2-alpha and their methods of useNOVARTIS AG·Filed 2021·Granted Feb 18, 2025·0 cites·30 claims
- 3351US2024116900A1New crystalline forms of a kras g12c inhibitor compoundNOVARTIS AG·Filed 2021·Application pending·0 cites
- 3450US11702409B2Pyrazolyl derivatives useful as anti-cancer agentsNOVARTIS AG·Filed 2020·Granted Jul 18, 2023·0 cites·34 claims
- 3549US9353354B2Bacterial iodoperoxidases from Zobellia galactanivorans, methods of preparation and uses thereofLEBLANC CATHERINE·Filed 2012·Granted May 31, 2016·0 cites·7 claims
- 3649US2011124693A15-phenyl-4-methyl-thiazol-2-yl-amine derivatives as inhibitors of phosphatidylinositol 3 kinase enzymes (pi3) for the treatment of inflammatory diseasesBLOOMFIELD GRAHAM CHARLES·Filed 2011·Application pending·0 cites
- 3749US2011124624A15-phenyl-4-methyl-thiazol-2-yl-amine derivatives as inhibitors of phosphatidylinositol 3 kinase enzymes (pi3) for the treatment of inflammatory diseasesBLOOMFIELD GRAHAM CHARLES·Filed 2011·Application pending·0 cites
- 3846US2018185341A1Use of ring-fused bicyclic pyridyl derivatives as fgfr4 inhibitorsNOVARTIS AG·Filed 2015·Application pending·0 cites
- 3945US2010041662A1Heterocyclic compounds as antiinflammatory agentsFERRAND SANDRINE·Filed 2007·Application pending·0 cites
- 4044US2009209552A1Organic CompoundsNOVARTIS AG·Filed 2007·Application pending·0 cites
- 4143US2014378463A1IP receptor agonist heterocyclic compoundsNOVARTIS AG·Filed 2013·Application pending·0 cites
- 4243US2008312229A1Organic CompoundsNOVARTIS AG·Filed 2006·Application pending·0 cites
- 4342US9604981B2IP receptor agonist heterocyclic compoundsNOVARTIS AG·Filed 2014·Granted Mar 28, 2017·0 cites·9 claims
- 4442US2007225335A1Pyrazole Derivatives for Treating Condit Ions Mediated by Activation of the Adeno Sine A2B or A3 ReceptorBLOOMFIELD GRAHAM C·Filed 2005·Application pending·0 cites
- 4541US2014357641A1IP receptor agonist heterocyclic compoundsNOVARTIS AG·Filed 2013·Application pending·0 cites
- 4641US2010087432A1Pyrrole derivatives having crth2 receptor antagonist activityADCOCK CLAIRE·Filed 2005·Application pending·0 cites
- 4741US2008312322A1Organic CompoundsBAETTIG URS·Filed 2006·Application pending·0 cites
- 4840US8017608B25-Phenylthiazole derivatives and their use as p13 kinase inhibitorsNOVARTIS AG·Filed 2004·Granted Sep 13, 2011·0 cites·8 claims
- 4940US7678826B2Organic compounds for the treatment of inflammatory or allergic conditionsAXFORD JAKE·Filed 2006·Granted Mar 16, 2010·0 cites·7 claims
- 5040US2015005311A1IP receptor agonist heterocyclic compoundsCHATLTON STEVEN CARL·Filed 2013·Application pending·0 cites
Showing the top 50 of 53 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →